SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is experiencing extreme volatility and a sharp sell-off following its recent quarterly financial results, with the community actively debating whether the decline is an overreaction to record-breaking revenue or a necessary market correction. Many investors are currently focused on whether this drawdown presents a buying opportunity, while others remain skeptical and caution against catching a falling knife.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant community attention as traders anticipate a pivotal regulatory decision regarding the sBLA filing for Anktiva, while monitoring recent earnings performance and international expansion efforts. The broader discussion is dominated by debates over non-cash accounting adjustments in the latest financial report and expectations for upcoming clinical data presentations.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending as investors react to a significant regulatory update regarding a potential FDA path forward for tabelecleucel, with the community actively debating the company's financial position and the likelihood of future capital raises. Traders are highlighting intense volatility and high volume as they monitor the stock's technical performance and assess the risk-reward profile ahead of upcoming regulatory milestones.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is seeing significant market interest as investors weigh its record $5.6 billion backlog and growing data center hyperscaler partnerships against ongoing profitability challenges. The community is actively debating whether the recent momentum represents a genuine re-rating of the company's long-term infrastructure potential or continued execution risk.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing extreme market volatility as investors weigh strong AI-driven demand and long-term revenue potential against supply chain constraints and a stretched valuation. While the community remains deeply divided between long-term bulls betting on the company's role as the architectural backbone of AGI and skeptics warning of a speculative bubble, price action continues to be driven by aggressive rotation and institutional profit-taking following recent earnings.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSSI is trending following an earnings report that showcased record-breaking revenue and profit growth, sparking intense community debate over whether the stock is undervalued or a temporary pump-and-dump. While bullish investors point to a massive AI infrastructure backlog and strategic partnerships with Dell as catalysts for a potential re-rate, skeptics are actively highlighting the lack of explicit revenue guidance and aggressive price volatility as reasons to lock in profits.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending due to a combination of strong institutional interest, strategic warrant exchanges aimed at reducing dilution, and a bullish growth outlook tied to its silicon anode battery technology for the drone and electric mobility sectors. The community remains focused on the company's long-term potential and operational milestones, often interpreting recent price volatility as a buying opportunity rather than a shift in fundamental strength.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors react to high-stakes speculation surrounding ongoing diplomatic and military maneuvers in the Strait of Hormuz. The community is actively debating the credibility of reported peace framework negotiations versus potential escalation, with many traders closely monitoring for signs of market manipulation and insider activity around the conflict.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently the center of intense investor focus as the community anticipates strong Q1 earnings and potential updates regarding the Neutron rocket, hypersonic defense contracts, and strategic acquisitions like Mynaric. Traders are closely monitoring these developments alongside broader sector rotation, with many viewing current price fluctuations as a consolidation phase before a potential rally fueled by the company's expanding backlog and pivotal role in U.S. national security infrastructure.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors weigh strong profitability and recent AAA-rated bond successes against broader geopolitical tensions and volatility in the fintech sector. While the community is actively debating the company's valuation gap compared to peers, sentiment remains divided between those expecting a potential short squeeze around upcoming earnings and skeptics focused on institutional insider selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MaxCyte (MXCT) Expected to Announce Quarterly Earnings on Tuesday

MaxCyte (NASDAQ:MXCT) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...

MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Rating of "Hold" from Brokerages

MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are covering the stock, MarketBeat reports. One equities research analyst...

Wall Street Zen Downgrades MaxCyte (NASDAQ:MXCT) to Sell

Wall Street Zen lowered MaxCyte from a "hold" rating to a "sell" rating in a report on Saturday...

MaxCyte (NASDAQ:MXCT) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of MaxCyte from a "sell" rating to a "hold" rating in a research note on Tuesday...

MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Brokerages

MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two...

Craig Hallum Issues Pessimistic Forecast for MaxCyte (NASDAQ:MXCT) Stock Price

Craig Hallum reduced their target price on MaxCyte from $7.00 to $5.00 and set a "buy" rating for the company in a research note on Wednesday...

MaxCyte (MXCT) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

MaxCyte Q4 Earnings Call Highlights

MaxCyte (NASDAQ:MXCT) executives told investors the company made meaningful progress in 2025 despite a difficult operating environment, highlighting continued strategic platform license (SPL...

MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates

MaxCyte (MXCT) delivered earnings and revenue surprises of +25.00% and -17.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

MaxCyte (NASDAQ:MXCT) Issues Earnings Results

MaxCyte (NASDAQ:MXCT - Get Free Report) released its earnings results on Tuesday. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by...

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.

MXCT
MaxCyte Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest MXCT News

MXCTMaxCyte Inc